Cargando…

152: A MEASURE FOR ESTIMATING THE MAGNITUDE OF UNNECESSARY OVERTREATMENT, OVER TESTING AND OVER PREVENTING

There is not any summary measure in EBM for showing the magnitude of unnecessary medical interventions including overtreatment, over testing and over preventing. Based on the finding of a valid and reliable double blinded randomized controlled clinical trial (RCT) with a good external validity, two...

Descripción completa

Detalles Bibliográficos
Autores principales: Pezeshki, Mohammad Zakaria, Pezeshki, Sina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759446/
http://dx.doi.org/10.1136/bmjopen-2016-015415.152
_version_ 1783291200742096896
author Pezeshki, Mohammad Zakaria
Pezeshki, Sina
author_facet Pezeshki, Mohammad Zakaria
Pezeshki, Sina
author_sort Pezeshki, Mohammad Zakaria
collection PubMed
description There is not any summary measure in EBM for showing the magnitude of unnecessary medical interventions including overtreatment, over testing and over preventing. Based on the finding of a valid and reliable double blinded randomized controlled clinical trial (RCT) with a good external validity, two groups of patients may receive unnecessary overtreatment: the first group consists of patients who will not respond to medication or surgery. The second group consists of patients who respond to the placebo or sham surgery. Here we define an index to cover these two groups: Unnecessary Overtreatment Index (UOI). Based on the finding of RCTs, the UOI is defined as summation of two proportions: the proportion of patients who do not respond to medication/surgery and the proportion of patients who are improved by the placebo or sham surgery intervention as well. For example if the RCT shows that 30/100 of patients who received medication/surgery have improved and for the placebo intervention group only 20/100 patients have also improved, then the UOI is summation of (1–30/100) and 20/100. It means if a physician prescribes the medication/surgery to 100 patients then 90 of these patients will be treated unnecessarily. Seventy out of 90 are patients who will not be improved and 20 out of 90 are patients who would be improved even if they received placebo intervention. The 95% Confidence Interval can be calculated for UOI. An interesting point is the relation of UOI with Absolute Risk Reduction (ARR). Considering the definition of UOI and ARR, we will show that UOI is equal to “1- ARR. As in the example, ARR is 10/100 (30/100–20/100). Then, it can be stated that UOI=1–10%=90%. If the RCT is a diagnostic trial examining a diagnostic test, then we can define Unnecessary Overtesting Index and if the RCT examines a preventive intervention, we can define Unnecessary Over preventing Index. The utility of UOI in clinical practice will be discussed with demonstrating a few examples.
format Online
Article
Text
id pubmed-5759446
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57594462018-02-12 152: A MEASURE FOR ESTIMATING THE MAGNITUDE OF UNNECESSARY OVERTREATMENT, OVER TESTING AND OVER PREVENTING Pezeshki, Mohammad Zakaria Pezeshki, Sina BMJ Open Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira There is not any summary measure in EBM for showing the magnitude of unnecessary medical interventions including overtreatment, over testing and over preventing. Based on the finding of a valid and reliable double blinded randomized controlled clinical trial (RCT) with a good external validity, two groups of patients may receive unnecessary overtreatment: the first group consists of patients who will not respond to medication or surgery. The second group consists of patients who respond to the placebo or sham surgery. Here we define an index to cover these two groups: Unnecessary Overtreatment Index (UOI). Based on the finding of RCTs, the UOI is defined as summation of two proportions: the proportion of patients who do not respond to medication/surgery and the proportion of patients who are improved by the placebo or sham surgery intervention as well. For example if the RCT shows that 30/100 of patients who received medication/surgery have improved and for the placebo intervention group only 20/100 patients have also improved, then the UOI is summation of (1–30/100) and 20/100. It means if a physician prescribes the medication/surgery to 100 patients then 90 of these patients will be treated unnecessarily. Seventy out of 90 are patients who will not be improved and 20 out of 90 are patients who would be improved even if they received placebo intervention. The 95% Confidence Interval can be calculated for UOI. An interesting point is the relation of UOI with Absolute Risk Reduction (ARR). Considering the definition of UOI and ARR, we will show that UOI is equal to “1- ARR. As in the example, ARR is 10/100 (30/100–20/100). Then, it can be stated that UOI=1–10%=90%. If the RCT is a diagnostic trial examining a diagnostic test, then we can define Unnecessary Overtesting Index and if the RCT examines a preventive intervention, we can define Unnecessary Over preventing Index. The utility of UOI in clinical practice will be discussed with demonstrating a few examples. BMJ Publishing Group 2017-02-08 /pmc/articles/PMC5759446/ http://dx.doi.org/10.1136/bmjopen-2016-015415.152 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira
Pezeshki, Mohammad Zakaria
Pezeshki, Sina
152: A MEASURE FOR ESTIMATING THE MAGNITUDE OF UNNECESSARY OVERTREATMENT, OVER TESTING AND OVER PREVENTING
title 152: A MEASURE FOR ESTIMATING THE MAGNITUDE OF UNNECESSARY OVERTREATMENT, OVER TESTING AND OVER PREVENTING
title_full 152: A MEASURE FOR ESTIMATING THE MAGNITUDE OF UNNECESSARY OVERTREATMENT, OVER TESTING AND OVER PREVENTING
title_fullStr 152: A MEASURE FOR ESTIMATING THE MAGNITUDE OF UNNECESSARY OVERTREATMENT, OVER TESTING AND OVER PREVENTING
title_full_unstemmed 152: A MEASURE FOR ESTIMATING THE MAGNITUDE OF UNNECESSARY OVERTREATMENT, OVER TESTING AND OVER PREVENTING
title_short 152: A MEASURE FOR ESTIMATING THE MAGNITUDE OF UNNECESSARY OVERTREATMENT, OVER TESTING AND OVER PREVENTING
title_sort 152: a measure for estimating the magnitude of unnecessary overtreatment, over testing and over preventing
topic Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Ira
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759446/
http://dx.doi.org/10.1136/bmjopen-2016-015415.152
work_keys_str_mv AT pezeshkimohammadzakaria 152ameasureforestimatingthemagnitudeofunnecessaryovertreatmentovertestingandoverpreventing
AT pezeshkisina 152ameasureforestimatingthemagnitudeofunnecessaryovertreatmentovertestingandoverpreventing